Sangamo Therapeutics IncNASDAQ:SGMO
- LAST PRICE1.9600
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.9600/ 11
- Ask / Lots1.9900/ 4
- Open / Previous Close--- / 1.9600
- Day Range---
- 52 Week Range
- Volume2,196
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SGMO |
|---|---|---|
| 09:32 ET | 55228 | 1.92 |
| 09:33 ET | 43760 | 1.9091 |
| 09:35 ET | 25890 | 1.9212 |
| 09:37 ET | 13231 | 1.9298 |
| 09:39 ET | 22724 | 1.9395 |
| 09:42 ET | 31215 | 1.9265 |
| 09:44 ET | 6484 | 1.9213 |
| 09:46 ET | 3931 | 1.925 |
| 09:48 ET | 9506 | 1.935 |
| 09:50 ET | 20470 | 1.92 |
| 09:51 ET | 27222 | 1.9449 |
| 09:53 ET | 19518 | 1.9299 |
| 09:55 ET | 35519 | 1.92 |
| 09:57 ET | 24510 | 1.9201 |
| 10:00 ET | 8549 | 1.925 |
| 10:02 ET | 15455 | 1.9103 |
| 10:04 ET | 5176 | 1.9109 |
| 10:06 ET | 16859 | 1.905 |
| 10:08 ET | 8015 | 1.9 |
| 10:09 ET | 21774 | 1.905 |
| 10:11 ET | 28694 | 1.915 |
| 10:13 ET | 2396 | 1.92 |
| 10:15 ET | 6224 | 1.935 |
| 10:18 ET | 8744 | 1.94 |
| 10:20 ET | 40202 | 1.95 |
| 10:22 ET | 10600 | 1.96 |
| 10:24 ET | 5651 | 1.96 |
| 10:26 ET | 8518 | 1.94 |
| 10:27 ET | 13285 | 1.93 |
| 10:29 ET | 10950 | 1.9201 |
| 10:31 ET | 17446 | 1.91 |
| 10:33 ET | 16807 | 1.9 |
| 10:36 ET | 21932 | 1.9098 |
| 10:38 ET | 14204 | 1.915 |
| 10:40 ET | 1439 | 1.91 |
| 10:42 ET | 3683 | 1.9194 |
| 10:44 ET | 100 | 1.91 |
| 10:45 ET | 1216 | 1.91 |
| 10:47 ET | 6709 | 1.921 |
| 10:49 ET | 39776 | 1.91 |
| 10:51 ET | 8047 | 1.925 |
| 10:54 ET | 4748 | 1.925 |
| 10:56 ET | 5048 | 1.94 |
| 10:58 ET | 28409 | 1.95 |
| 11:00 ET | 5143 | 1.94 |
| 11:02 ET | 16797 | 1.935 |
| 11:03 ET | 2741 | 1.936 |
| 11:05 ET | 3816 | 1.935 |
| 11:07 ET | 32576 | 1.9391 |
| 11:09 ET | 6049 | 1.925 |
| 11:12 ET | 7787 | 1.92 |
| 11:14 ET | 20790 | 1.9208 |
| 11:16 ET | 14848 | 1.95 |
| 11:18 ET | 13523 | 1.94 |
| 11:20 ET | 1528 | 1.9431 |
| 11:21 ET | 6254 | 1.945 |
| 11:23 ET | 14002 | 1.955 |
| 11:25 ET | 15310 | 1.960799 |
| 11:27 ET | 11100 | 1.9603 |
| 11:30 ET | 2804 | 1.96 |
| 11:32 ET | 3300 | 1.9689 |
| 11:34 ET | 11388 | 1.955 |
| 11:36 ET | 13727 | 1.975 |
| 11:38 ET | 12672 | 1.9795 |
| 11:39 ET | 10659 | 1.985 |
| 11:41 ET | 8871 | 1.98 |
| 11:43 ET | 3517 | 1.97 |
| 11:45 ET | 19936 | 1.97 |
| 11:48 ET | 11032 | 1.965 |
| 11:52 ET | 1090 | 1.965 |
| 11:54 ET | 13325 | 1.97 |
| 11:56 ET | 1403 | 1.985 |
| 11:57 ET | 2200 | 1.985 |
| 11:59 ET | 4726 | 1.98 |
| 12:01 ET | 14133 | 1.975 |
| 12:03 ET | 1414 | 1.975 |
| 12:06 ET | 55675 | 1.9965 |
| 12:08 ET | 17710 | 1.995 |
| 12:10 ET | 6498 | 2.005 |
| 12:12 ET | 8083 | 2.0059 |
| 12:14 ET | 5864 | 2.001 |
| 12:15 ET | 55265 | 2.005 |
| 12:17 ET | 5404 | 2.005 |
| 12:19 ET | 5722 | 2.005 |
| 12:21 ET | 2805 | 2 |
| 12:24 ET | 10449 | 2 |
| 12:26 ET | 8368 | 1.995 |
| 12:28 ET | 7494 | 1.995 |
| 12:30 ET | 40419 | 2.02 |
| 12:32 ET | 16717 | 2.02 |
| 12:33 ET | 37403 | 2.02 |
| 12:35 ET | 3468 | 2.009399 |
| 12:37 ET | 4700 | 2 |
| 12:39 ET | 3431 | 2.015 |
| 12:42 ET | 2573 | 2.0104 |
| 12:44 ET | 12264 | 2.0101 |
| 12:46 ET | 23943 | 2.015 |
| 12:48 ET | 15789 | 2.0127 |
| 12:50 ET | 27107 | 2.005 |
| 12:51 ET | 10460 | 2.005 |
| 12:53 ET | 5400 | 2.005 |
| 12:55 ET | 38170 | 2.005 |
| 12:57 ET | 14684 | 2.0053 |
| 01:00 ET | 20928 | 1.99 |
| 01:02 ET | 4085 | 1.99 |
| 01:04 ET | 41415 | 2 |
| 01:06 ET | 1400 | 2.001 |
| 01:08 ET | 696 | 2.005 |
| 01:09 ET | 13454 | 2.005 |
| 01:11 ET | 16346 | 2.005 |
| 01:13 ET | 1976 | 2.0138 |
| 01:15 ET | 8914 | 2.01 |
| 01:18 ET | 5689 | 2.005 |
| 01:20 ET | 600 | 2.005 |
| 01:22 ET | 24461 | 2 |
| 01:24 ET | 11261 | 2 |
| 01:26 ET | 5900 | 2 |
| 01:27 ET | 100 | 2 |
| 01:29 ET | 52670 | 2.015 |
| 01:31 ET | 9046 | 2.02 |
| 01:33 ET | 17275 | 2.01 |
| 01:36 ET | 7790 | 2.0111 |
| 01:38 ET | 4156 | 2.0175 |
| 01:40 ET | 12428 | 2 |
| 01:42 ET | 6604 | 1.99 |
| 01:44 ET | 14980 | 2 |
| 01:45 ET | 3453 | 2 |
| 01:47 ET | 1003 | 1.99 |
| 01:49 ET | 11165 | 1.985 |
| 01:51 ET | 15110 | 1.985 |
| 01:54 ET | 32902 | 1.985 |
| 01:56 ET | 12200 | 1.985 |
| 01:58 ET | 2922 | 1.985 |
| 02:00 ET | 1478 | 1.985 |
| 02:02 ET | 9468 | 1.98 |
| 02:03 ET | 16853 | 1.99 |
| 02:05 ET | 1140 | 1.985 |
| 02:07 ET | 9688 | 1.97 |
| 02:09 ET | 15377 | 1.97 |
| 02:12 ET | 17550 | 1.97 |
| 02:14 ET | 6507 | 1.965 |
| 02:16 ET | 29040 | 1.96 |
| 02:18 ET | 6779 | 1.9649 |
| 02:20 ET | 20512 | 1.955 |
| 02:21 ET | 22452 | 1.95 |
| 02:23 ET | 10790 | 1.965 |
| 02:25 ET | 1180 | 1.965 |
| 02:27 ET | 3050 | 1.965 |
| 02:30 ET | 1950 | 1.97 |
| 02:32 ET | 6717 | 1.965 |
| 02:34 ET | 7584 | 1.975 |
| 02:36 ET | 13531 | 1.975 |
| 02:38 ET | 41137 | 1.9689 |
| 02:39 ET | 1227 | 1.975 |
| 02:41 ET | 14941 | 1.975 |
| 02:43 ET | 12525 | 1.97 |
| 02:45 ET | 13983 | 1.965 |
| 02:48 ET | 20580 | 1.97 |
| 02:50 ET | 30548 | 1.97 |
| 02:52 ET | 11652 | 1.96 |
| 02:54 ET | 14810 | 1.96 |
| 02:56 ET | 1275 | 1.96 |
| 02:57 ET | 10761 | 1.9601 |
| 02:59 ET | 15796 | 1.95 |
| 03:01 ET | 11255 | 1.955 |
| 03:03 ET | 23785 | 1.96 |
| 03:06 ET | 15892 | 1.95 |
| 03:08 ET | 3016 | 1.955 |
| 03:10 ET | 7528 | 1.965 |
| 03:12 ET | 2120 | 1.965 |
| 03:14 ET | 3669 | 1.9645 |
| 03:15 ET | 10641 | 1.955 |
| 03:17 ET | 47078 | 1.95 |
| 03:19 ET | 10400 | 1.955 |
| 03:21 ET | 18735 | 1.965 |
| 03:24 ET | 7682 | 1.96 |
| 03:26 ET | 16388 | 1.96 |
| 03:28 ET | 8660 | 1.965 |
| 03:30 ET | 1091 | 1.965 |
| 03:32 ET | 4598 | 1.965 |
| 03:33 ET | 39976 | 1.9715 |
| 03:35 ET | 21300 | 1.9789 |
| 03:37 ET | 31761 | 1.965 |
| 03:39 ET | 22913 | 1.965 |
| 03:42 ET | 15936 | 1.9689 |
| 03:44 ET | 33707 | 1.965 |
| 03:46 ET | 34938 | 1.965 |
| 03:48 ET | 72299 | 1.965 |
| 03:50 ET | 14244 | 1.965 |
| 03:51 ET | 20070 | 1.95 |
| 03:53 ET | 43864 | 1.96 |
| 03:55 ET | 7600 | 1.965 |
| 03:57 ET | 63029 | 1.955 |
| 04:00 ET | 142474 | 1.96 |
Nov 19, 2024
DJ Sangamo Therapeutics Gets FDA Clearance for Investigational NDA for Pain Treatment, from 4:41PM ET on Tuesday Nov 19, 2024 by Dow Jones
4:41PM ET on Tuesday Nov 19, 2024 by Dow JonesSangamo Therapeutics Announces U.S. FDA Clearance of IND Application for ST-503 for the Treatment of Idiopathic Small Fiber Neuropathy, a Type of Chronic Neuropathic Pain, from 4:15PM ET on Tuesday Nov 19, 2024 by Dow Jones
4:15PM ET on Tuesday Nov 19, 2024 by Dow Jones
Nov 14, 2024
DJ Sangamo Therapeutics Price Target Maintained With a $10.00/Share by HC Wainwright & Co., from 1:29PM ET on Thursday Nov 14, 2024 by Dow Jones
1:29PM ET on Thursday Nov 14, 2024 by Dow JonesDJ Sangamo Therapeutics Is Maintained at Overweight by Barclays, from 9:23AM ET on Thursday Nov 14, 2024 by Dow Jones
9:23AM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 12, 2024
Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter 2024 Financial Results, from 4:01PM ET on Tuesday Nov 12, 2024 by Dow Jones
4:01PM ET on Tuesday Nov 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Sangamo Therapeutics Inc | 408.1M | -2.8x | --- |
Arcturus Therapeutics Holdings Inc | 462.4M | -7.3x | --- |
Akebia Therapeutics Inc | 397.1M | -8.2x | --- |
Vanda Pharmaceuticals Inc | 288.0M | -17.5x | -37.98% |
Kamada Ltd | 336.3M | 18.9x | -22.48% |
Adaptive Biotechnologies Corp | 644.9M | -3.3x | --- |
Company Information
Sangamo Therapeutics, Inc. is a genomic medicines company that is developing medicines for neurological diseases. The Company's neurology preclinical development is focused on two areas: development of epigenetic regulation therapies to treat serious neurological diseases, and development of novel engineered adeno-associated virus (AAV) capsids to deliver its therapies to the intended neurological targets. The Company's zinc finger epigenetic regulators are ideally suited to potentially address neurological disorders and its capsid discovery platform is expanding delivery beyond intrathecal delivery capsids, including in the central nervous system. Its clinical-stage product candidates are Isaralgagene civaparvovec, also known as ST-920, its wholly-owned gene therapy product candidate for the treatment of Fabry disease, and TX200, its wholly-owned CAR-Treg cell therapy product candidate for the prevention of immune-mediated rejection in HLA-A2 mismatched kidney transplantation.
Contact Information
- Headquarters
- 501 Canal Blvd.RICHMOND, CA, United States 94084
- Phone
- 510-970-6000
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- H. Stewart Parker
- President, Chief Executive Officer, Director
- Alexander Macrae
- Principal Financial Officer, Principal Accounting Officer, Vice President - Finance
- Prathyusha Duraibabu
- Senior Vice President, General Counsel, Corporate Secretary
- Scott Willoughby
- Senior Vice President, Chief Development Officer
- Nathalie Dubois- Stringfellow
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $408.1M |
|---|---|
Revenue (TTM) | $52.3M |
Shares Outstanding | 208.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.10 |
EPS | $-0.71 |
Book Value | $0.47 |
P/E Ratio | -2.8x |
Price/Sales (TTM) | 7.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -267.81% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
